You are here: Welcome » COVID-19 Vaccines » COVID-19 Vaccine Efficacy

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
Both sides next revision
covid-19_vaccines:efficacy [2022/09/23 18:47]
mathew 		covid-19_vaccines:efficacy [2022/10/21 18:11] (current)
xinke [Waning Efficacy]
Line 25: Line 25:
   * Sep 28, 2021 - Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers((September 28, 2021 | Jean-Louis Bayart et al | Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers | [[https://www.mdpi.com/2076-393X/9/10/1092/htm#app1-vaccines-09-01092|https://doi.org/10.3390/vaccines9101092]]))   * Sep 28, 2021 - Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers((September 28, 2021 | Jean-Louis Bayart et al | Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers | [[https://www.mdpi.com/2076-393X/9/10/1092/htm#app1-vaccines-09-01092|https://doi.org/10.3390/vaccines9101092]]))
   * Nov 18, 2021 - Isolation of 4000 SARS-CoV-2 shows that contagiousness is associated with viral load, not vaccine or symptomatic status((November 18, 2021 | Celine Boschi et al | Emerging Microbes and Infections | Isolation of 4000 SARS-CoV-2 shows that contagiousness is associated with viral load, not vaccine or symptomatic status | [[https://cogentoa.tandfonline.com/doi/full/10.1080/22221751.2021.2008776|doi.org/10.1080/22221751.2021.2008776]]))   * Nov 18, 2021 - Isolation of 4000 SARS-CoV-2 shows that contagiousness is associated with viral load, not vaccine or symptomatic status((November 18, 2021 | Celine Boschi et al | Emerging Microbes and Infections | Isolation of 4000 SARS-CoV-2 shows that contagiousness is associated with viral load, not vaccine or symptomatic status | [[https://cogentoa.tandfonline.com/doi/full/10.1080/22221751.2021.2008776|doi.org/10.1080/22221751.2021.2008776]]))
 +  * June 23, 2022 - Comparative effectiveness and durability of COVID‐19 vaccination against death and severe disease in an ongoing nationwide mass vaccination campaign((June 23, 2022 | Theodore Lytras et al | J Med Virol | Comparative effectiveness and durability of COVID‐19 vaccination against death and severe disease in an ongoing nationwide mass vaccination campaign | [[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349766/|doi: 10.1002/jmv.27934]]))
 +    * The lead author and a co-authored also authored a paper in support of lockdowns. That co-author is a spokesman with a spokesman for the [[Hellenic Ministry of Health]].((February, 2021 | Theodore Lytras and Sotirios Tsiodra | Scand J Public Health | Lockdowns and the COVID-19 pandemic: What is the endgame? | [[https://pubmed.ncbi.nlm.nih.gov/32981448/|DOI: 10.1177/1403494820961293]]))
 +    * The waning of VE from 90% to 80% is substantially less than from other reported retrospective results.
 +    * Says the olderly are more than 1000x as at risk as the young without even a word suggesting that absolute benefits may not justify the risks for the young.
  
  
Line 73: Line 77:
  
 === Waning Booster Efficacy === === Waning Booster Efficacy ===
-Medpage Today reported that COVID vaccine booster efficacy may want quickly.((December 28, 2021 | MedPage Today | [[https://www.medpagetoday.com/special-reports/exclusives/96412|COVID Vaccine Booster Efficacy Against Infection May Fade Quickly]]))+Medpage Today reported that COVID vaccine booster efficacy may wane quickly.((December 28, 2021 | MedPage Today | [[https://www.medpagetoday.com/special-reports/exclusives/96412|COVID Vaccine Booster Efficacy Against Infection May Fade Quickly]]))
  
 ==== Efficacy by Variant ==== ==== Efficacy by Variant ====
Back to top